Abstract:Objective: To analyze the clinicopathological characteristics of mucosa associated lymphoid tissue (MALT) lymphoma secondary to Sjögren' s syndrome (SS) (SS-MALT lymphoma) in salivary gland and to explore the value of the combined application of histopathological morphology, protein expression and molecular phenotype in pathological diagnosis and prognostic evaluation of SS-MALT lymphoma. Methods: Sixteen patients with SS-MALT lymphoma were collected from 260 patients who were diagnosed with SS in Peking University School and Hospital of Stomatology from January 1997 to December 2016. Twelve patients with non-MALT lymphoma secondary to SS (non-SS-MALT lymphoma) in salivary gland were selected as controls. The clinical data of the patients were retrospectively reviewed and analyzed. All the patients were followed up until December 20, 2019. Hematoxylin-eosin staining, immunohistochemistry, polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) techniques were used to observe the histologic characteristics and to detect the manifestations of light chain restrictive expression, immunoglobulin (Ig) gene clonal rearrangement, chromosome translocation and gene abnormality, so as to evaluate their values in pathological diagnosis and prognostic evaluation. Results: The malignant transformation rate of SS to MALT lymphoma was about 6.15%, ranged from 3 to 240 months, during which 2 patients died due to high-level deterioration. Microscopically, the acini of the glandular tissue were atrophied and destroyed. The tumor cells dominated by central cell-like lymphocytes grew diffusely, destroying the epithelial islands. All SS-MALT lymphoma cases were positive in CD20 and Pax5. Half of them had the Ki-67 proliferation index of 10% or less, and half greater than 10%. 93.75% cases expressed AE1/AE3 protein, which showed the residual glandular epithelium. All the tumor cells were negative in CD3ε, and the plasma cells were detected by CD138 antigen. The light chain restrictive expression of κ and λ was 37.5% in SS-MALT lymphoma group. The positive detection rates of immunoglobulin heavy chain (IgH)-FR1, IgH-FR2, IgH-FR3, immunoglobulin kappa chain (IgK)-A, and IgK-B in SS-MALT lymphoma group were 33.3%, 53.3%, 33.3%, 20.0%, and 26.7%, respectively, and 93.3% when together used with IgH and IgK. The positive rates of the MALT1, IGH and BCL6 genes with dual color break-apart probes were 36.4%, 27.3% and 27.3%, and the detection rate of chromosome translocation and gene abnormality by applying the three probes was 72.7%. Conclusion: There are no specific histological characteristics and protein phenotypes in the histologic diagnosis of SS-MALT lymphoma in salivary gland. The combined application of histopathological manifestations, immunohistochemistry, PCR and FISH techniques helps the accurate pathologic diagnosis of the disease. Although SS-MALT lymphoma is considered as an indolent lymphoma with a relatively favorable prognosis, the regular return visit and long-term follow-up should be conducted to detect the clues of recurrence and advanced deterioration.

Mucosa-associated lymphoid tissue lymphoma of the salivary glands: MR imaging findings including diffusion-weighted imaging

Gastrointestinal mucosa-associated lymphoid tissue lymphoma (report of 6 cases with literatures review)

Application of Ultrasound and Contrast-Enhanced Ultrasound to Distinguish Salivary Focal Inflammatory Masses from Malignant Masses: A Retrospective Observational Study

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings in Mucosa-Associated Lymphoid Tissue Lymphoma of the Larynx: A Case Report and Literature Review

Parotid gland MALT lymphoma with amyloid deposition, challenges in preoperative diagnosis: A case report

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.

The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.

[Clinicopathologic Characteristics and Chromosomal Abnormalities in Salivary Mucosa Associated Lymphoid Tissue Lymphomas].

Multimodality Fmri with Perfusion, Diffusion‐weighted MRI and 1H‐MRS in the Diagnosis of Lympho‐associated Benign and Malignant Lesions of the Parotid Gland

Application of MR diffusion-weighted imaging in the evaluation of salivary glands with gustatory stimulation

Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors

Dynamic Contrast-Enhanced MR in the Diagnosis of Lympho-Associated Benign and Malignant Lesions in the Parotid Gland.

Malignant or benign salivary gland lesions: predicting with MR imaging

[Clinical and imaging manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma]

Author Response for "clinicopathological Aspects of Primary Mucosa‐associated Lymphoid Tissue Lymphoma of the Salivary Gland: a Retrospective Single‐center Analysis of 72 Cases"

[(18)F-Fluorodeoxy Glucose Positron Emission Tomography/computed Tomography Manifestation and Clinical Characteristics of Primary Salivary Gland-Type Lung Cancer].

[Clinicopathological analysis of mucosa associated lymphoid tissue lymphoma secondary to Sjögren' s syndrome in salivary gland]

Preliminary Study of Diffusion-Weighted Imaging and Magnetic Resonance Spectroscopy Imaging in Kimura Disease

Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy